_id
691481fbccc777a4e85d9373
Ticker
NIKA
Name
Nika BioTechnology Inc
Exchange
PINK
Address
2269 Merrimack Valley Avenue, Henderson, NV, United States, 89044
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.nikapharmaceuticals.com
Description
Nika Pharmaceuticals, Inc., a pharmaceutical company, develops drugs for the treatment of HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, diabetes, and various other diseases. It offers dietary supplements and antiviral drugs, as well as thymus nuclear glycoprotein for the treatment of HIV. The company was formerly known as Centennial Growth Equities Inc. and changed its name to Nika Pharmaceuticals, Inc. in May 2022. Nika Pharmaceuticals, Inc. was incorporated in 2000 and is based in Henderson, Nevada.
Last Close
0.3801
Volume
-
Current Price
0.3801
Change
42.85714285714285
Last Updated
2026-01-05T11:25:26.273Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
395241696
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
7982
Operating Income
-7999
Interest Expense
-
Pretax Income
-7999
Net Income
-7999
Eps
-0.000007692559211260237
Dividends Per Share
-
Shares Outstanding
1039836001
Income Tax Expense
-
EBITDA
-7999
Operating Margin
-
Total Other Income Expense Net
-
Cash
6287
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
23625
Property Plant Equipment
-
Total Assets
23625
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
284164
Equity
-260539
Bs_currency_symbol
USD
Depreciation
-
Change In Working Capital
-1347
Cash From Operations
-9329
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
0
Net Change In Cash
-9329
Cf_currency_symbol
USD
PE
0
PB
-1517.0153550907924
ROE
3.070173755176768
ROA
-33.85820105820106
FCF
-9329
Fcf Percent
-
Piotroski FScore
0
Health Score
25
Deep Value Investing Score
1
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
0.5
Quality Investing Score
1
Value Investing Score
1
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
7982
Quarters > 0 > income Statement > operating Income
-7999
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-7999
Quarters > 0 > income Statement > net Income
-7999
Quarters > 0 > income Statement > eps
-0.000007692559211260237
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1039836000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-7999
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
6287
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
23625
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
23625
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
284164
Quarters > 0 > balance Sheet > equity
-260539
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-7982
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-1347
Quarters > 0 > cash Flow > cash From Operations
-9329
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-9329
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.000007692559211260237
Quarters > 0 > ratios > PB
-1517.0153550907924
Quarters > 0 > ratios > ROE
3.070173755176768
Quarters > 0 > ratios > ROA
-33.85820105820106
Quarters > 0 > ratios > FCF
-9329
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
25
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
18381
Quarters > 1 > income Statement > operating Income
-18381
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-18381
Quarters > 1 > income Statement > net Income
-18381
Quarters > 1 > income Statement > eps
-0.00001790811823001814
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
1026406000
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-18381
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
15616
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
31607
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
31607
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
284164
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
284164
Quarters > 1 > balance Sheet > equity
-252557
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-18382
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-140
Quarters > 1 > cash Flow > cash From Operations
-18522
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
15000
Quarters > 1 > cash Flow > net Change In Cash
-3521
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.00001790811823001814
Quarters > 1 > ratios > PB
-1544.747999857458
Quarters > 1 > ratios > ROE
7.277961014741227
Quarters > 1 > ratios > ROA
-58.154839117916914
Quarters > 1 > ratios > FCF
-18522
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
28
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
12945
Quarters > 2 > income Statement > operating Income
-12945
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-12945
Quarters > 2 > income Statement > net Income
-12945
Quarters > 2 > income Statement > eps
-0.000012612398440719778
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
1026371000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-12945
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
19137
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
34988
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
34988
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
269164
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
269164
Quarters > 2 > balance Sheet > equity
-234176
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-12945
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-12945
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
30000
Quarters > 2 > cash Flow > net Change In Cash
17054
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.000012612398440719778
Quarters > 2 > ratios > PB
-1665.9419287202788
Quarters > 2 > ratios > ROE
5.527893550150314
Quarters > 2 > ratios > ROA
-36.998399451240424
Quarters > 2 > ratios > FCF
-12945
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
27
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
-156
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-156
Quarters > 3 > income Statement > operating Expenses
-33519
Quarters > 3 > income Statement > operating Income
33363
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
33363
Quarters > 3 > income Statement > net Income
-12453
Quarters > 3 > income Statement > eps
-0.000012226570036214328
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
1018519500
Quarters > 3 > income Statement > income Tax Expense
43276
Quarters > 3 > income Statement > EBITDA
10651
Quarters > 3 > income Statement > operating Margin
-21386.53846153846
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
2083
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
17934
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
17934
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
239164
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
239164
Quarters > 3 > balance Sheet > equity
-221230
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-12453
Quarters > 3 > cash Flow > depreciation
12453
Quarters > 3 > cash Flow > change In Working Capital
-15851
Quarters > 3 > cash Flow > cash From Operations
-28303
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
29000
Quarters > 3 > cash Flow > net Change In Cash
697
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.000012226570036214328
Quarters > 3 > ratios > PB
-1749.9401615965285
Quarters > 3 > ratios > ROE
5.628983410929802
Quarters > 3 > ratios > ROA
-69.43793911007026
Quarters > 3 > ratios > FCF
-28303
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
181.42948717948718
Quarters > 3 > health Score
37
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
95792
Annuals > 0 > income Statement > operating Income
-95792
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-95792
Annuals > 0 > income Statement > net Income
-95792
Annuals > 0 > income Statement > eps
-0.00009375980314669692
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1021674500
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-95792
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
2083
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
17934
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
17934
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
239164
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
239164
Annuals > 0 > balance Sheet > equity
-221230
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-95792
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
-15851
Annuals > 0 > cash Flow > cash From Operations
-154932
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
137419
Annuals > 0 > cash Flow > net Change In Cash
-17513
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.00009375980314669692
Annuals > 0 > ratios > PB
-1755.3608346517199
Annuals > 0 > ratios > ROE
43.299733309225694
Annuals > 0 > ratios > ROA
-534.1362774618044
Annuals > 0 > ratios > FCF
-154932
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
64833
Annuals > 1 > income Statement > operating Income
-64833
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-64833
Annuals > 1 > income Statement > net Income
-64833
Annuals > 1 > income Statement > eps
-0.00007400267095846317
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
876090000
Annuals > 1 > income Statement > income Tax Expense
-64833
Annuals > 1 > income Statement > EBITDA
-64833
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
19596
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
19596
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
19596
Annuals > 1 > balance Sheet > payables
-
Annuals > 1 > balance Sheet > short Term Debt
101745
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
101745
Annuals > 1 > balance Sheet > equity
-82149
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-64833
Annuals > 1 > cash Flow > depreciation
64833
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-64833
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
83565
Annuals > 1 > cash Flow > net Change In Cash
18732
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.00007400267095846317
Annuals > 1 > ratios > PB
-4053.631924916919
Annuals > 1 > ratios > ROE
78.92122849943397
Annuals > 1 > ratios > ROA
-330.8481322718922
Annuals > 1 > ratios > FCF
-64833
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
3183715
Annuals > 2 > income Statement > operating Income
-3183715
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-3183715
Annuals > 2 > income Statement > net Income
-3183715
Annuals > 2 > income Statement > eps
-0.003634004497254848
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
876090000
Annuals > 2 > income Statement > income Tax Expense
-3183715
Annuals > 2 > income Statement > EBITDA
-3183715
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
1
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
864
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
864
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
864
Annuals > 2 > balance Sheet > payables
-
Annuals > 2 > balance Sheet > short Term Debt
18180
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
18180
Annuals > 2 > balance Sheet > equity
-17316
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-3183715
Annuals > 2 > cash Flow > depreciation
3183715
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-33715
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
34180
Annuals > 2 > cash Flow > net Change In Cash
465
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.003634004497254848
Annuals > 2 > ratios > PB
-19230.873700623702
Annuals > 2 > ratios > ROE
18385.97251097251
Annuals > 2 > ratios > ROA
-368485.5324074074
Annuals > 2 > ratios > FCF
-33715
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
85216
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
85216
Annuals > 3 > income Statement > operating Expenses
14712
Annuals > 3 > income Statement > operating Income
-14712
Annuals > 3 > income Statement > interest Expense
3489
Annuals > 3 > income Statement > pretax Income
-14712
Annuals > 3 > income Statement > net Income
-14712
Annuals > 3 > income Statement > eps
-0.00001679279526076088
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
876090000
Annuals > 3 > income Statement > income Tax Expense
-14712
Annuals > 3 > income Statement > EBITDA
-14712
Annuals > 3 > income Statement > operating Margin
-17.26436349981224
Annuals > 3 > income Statement > total Other Income Expense Net
-146267
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
399
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
41772
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
399
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
399
Annuals > 3 > balance Sheet > payables
37788
Annuals > 3 > balance Sheet > short Term Debt
10518
Annuals > 3 > balance Sheet > long Term Debt
13500
Annuals > 3 > balance Sheet > total Liabilities
24018
Annuals > 3 > balance Sheet > equity
-23619
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-14712
Annuals > 3 > cash Flow > depreciation
14712
Annuals > 3 > cash Flow > change In Working Capital
103811
Annuals > 3 > cash Flow > cash From Operations
-14712
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-6943
Annuals > 3 > cash Flow > cash From Financing
13500
Annuals > 3 > cash Flow > net Change In Cash
-1212
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.00001679279526076088
Annuals > 3 > ratios > PB
-14098.895338498665
Annuals > 3 > ratios > ROE
62.28883525974851
Annuals > 3 > ratios > ROA
-3687.218045112782
Annuals > 3 > ratios > FCF
-14712
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-0.1726436349981224
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.000007692559211260237
Valuation > metrics > PB
-1517.0153550907924
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
3.070173755176768
Profitability > metrics > ROA
-33.85820105820106
Profitability > final Score
21
Profitability > verdict
Weak
Risk > final Score
50
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
30
Prev Profitabilities > 1
26
Prev Profitabilities > 2
41
Prev Risks > 0
50
Prev Risks > 1
50
Prev Risks > 2
36
Prev Liquidities > 0
16
Prev Liquidities > 1
16
Prev Liquidities > 2
14
Updated At
2026-01-20T22:16:50.996Z
Earnings History > 0 > period
2023-12-31
Earnings History > 0 > report Date
2023-12-31
Earnings History > 0 > date
2023-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2023-09-30
Earnings History > 1 > report Date
2023-09-30
Earnings History > 1 > date
2023-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2023-06-30
Earnings History > 2 > report Date
2023-06-30
Earnings History > 2 > date
2023-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
0
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2023-03-31
Earnings History > 3 > report Date
2023-03-31
Earnings History > 3 > date
2023-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-12-31
Earnings History > 4 > report Date
2022-12-31
Earnings History > 4 > date
2022-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2022-06-30
Earnings History > 5 > report Date
2022-06-30
Earnings History > 5 > date
2022-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.0014
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2022-03-31
Earnings History > 6 > report Date
2022-03-31
Earnings History > 6 > date
2022-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.0005
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2021-12-31
Earnings History > 7 > report Date
2021-12-31
Earnings History > 7 > date
2021-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.0015
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2021-09-30
Earnings History > 8 > report Date
2021-09-30
Earnings History > 8 > date
2021-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.0004
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2021-06-30
Earnings History > 9 > report Date
2021-06-30
Earnings History > 9 > date
2021-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.0227
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2021-03-31
Earnings History > 10 > report Date
2021-03-31
Earnings History > 10 > date
2021-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0002
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2020-06-30
Earnings History > 11 > report Date
2020-06-30
Earnings History > 11 > date
2020-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.0002
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2020-03-31
Earnings History > 12 > report Date
2020-03-31
Earnings History > 12 > date
2020-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.0002
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-12-31
Earnings History > 13 > report Date
2018-12-31
Earnings History > 13 > date
2018-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.0012
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2018-09-30
Earnings History > 14 > report Date
2018-09-30
Earnings History > 14 > date
2018-09-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.0022
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2018-06-30
Earnings History > 15 > report Date
2018-06-30
Earnings History > 15 > date
2018-06-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.0014
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2018-03-31
Earnings History > 16 > report Date
2018-03-31
Earnings History > 16 > date
2018-03-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.0081
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2017-09-30
Earnings History > 17 > report Date
2017-09-30
Earnings History > 17 > date
2017-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.0048
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2017-06-30
Earnings History > 18 > report Date
2017-06-30
Earnings History > 18 > date
2017-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.0048
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2017-03-31
Earnings History > 19 > report Date
2017-03-31
Earnings History > 19 > date
2017-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.0041
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Nika Pharmaceuticals, Inc., a pharmaceutical company, develops drugs for the treatment of HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, diabetes, and various other diseases. It offers dietary supplements and antiviral drugs, as well as thymus nuclear glycoprotein for the treatment of HIV. The company was formerly known as Centennial Growth Equities Inc. and changed its name to Nika Pharmaceuticals, Inc. in May 2022. Nika Pharmaceuticals, Inc. was incorporated in 2000 and is based in Henderson, Nevada.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ALanphier boys basketball, Soriano Hayes' stock rise in win over SHG sj-r.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Nika BioTechnology Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2023-12-31
EPS Actual
0
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.